Clinical Trials Logo

Tumors With Aberrations in ALK clinical trials

View clinical trials related to Tumors With Aberrations in ALK.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT02465528 Terminated - Glioblastoma Clinical Trials

Ceritinib Rare Indications Study in ALK+ Tumors

Start date: May 6, 2016
Phase: Phase 2
Study type: Interventional

This is Proof-of-Concept (POC) study to assess the preliminary antitumor activity and safety and tolerablity using ceritinib (LDK378) in the treatment of life threatening tumors that are characterized by ALK genetic alteration (and/or overexpression in some diseases).